PATENT CLAIM ANALYSIS

Application Number: 16155041
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "210210"]

Abstract:
The specification relates to compounds of Formula (I): and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of cell proliferative disorders.

Claim (Index 3):
A compound of Formula (I) or a pharmaceutically acceptable salt thereof, as claimed in  claim 1 , wherein Q is O.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.25714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15782904', '15491345', '15657395', '15520491', '15316543']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7948767693718416
- 35 USC 102 Novelty (BERT): 0.7302089343331115
- Combined Prediction Score: 0.7884099858679686
- Mean Citation Score: 550.8803019999998
- Max Citation Score: 1051.9388
- Similarity Product: 781.3239582381246

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test